Skip to main content
. 2014 Feb 19;9(2):e89324. doi: 10.1371/journal.pone.0089324

Figure 3. Distribution of indication classes in predicted novel usages.

Figure 3

Each indication for the 403 high confidence novel usages with support in FAERS and MEDLINE was mapped to the first level of the NDF-RT disease hierarchy. 63 usages were not mapped to NDF-RT and were left out of this chart.

HHS Vulnerability Disclosure